Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Tenon Medical Q4 2025 Earnings Call - SImmetry+ Clearance Spurs Q4 Revenue Surge as Multi-Product Play Begins
Tenon closed 2025 with clear commercial momentum, reporting record full-year revenue of $3.9 million, up 20% year over year, and a breakout fourth quarter at $1.5 million, up 92% from Q4 2024. Managem...
- Record full-year revenue of $3.9 million for 2025, a 20% increase versus 2024; Q4 revenue was $1.5 million, up 92% year over year.
- Management credits back-half 2025 momentum and new physician users across Catamaran and SImmetry+ for the revenue gains.
- Tenon received FDA 510(k) clearance for the next-generation SImmetry+ SI joint fusion system, adding a lateral approach to its portfolio.
- +12 more takeaways
Curis Q4 2025 Earnings Call - PCNSL Take Aim registrational study on track for accelerated submissions
Curis reported steady clinical progress and a cleaner balance sheet in Q4 2025. The company reiterated that its Take Aim Lymphoma registrational trial in primary CNS lymphoma is enrolling on plan, wit...
- Take Aim Lymphoma is a single-arm registrational study in primary CNS lymphoma evaluating emavusertib plus ibrutinib with an ORR endpoint, intended to support accelerated submissions in the U.S. and Europe after FDA and EMA discussions.
- Company says enrollment in the PCNSL trial is on track, but cautions patient accrual is choppy given the rarity of the indication, estimating full enrollment in roughly 12 to 18 months.
- Curis is prioritizing NHL programs, specifically PCNSL for registration and CLL for proof of concept, ahead of further investment in AML.
- +11 more takeaways
Mount Logan Capital Q4 and Full Year 2025 Earnings Call - Yieldstreet Deal to Nearly Double SOFIX and Add ~30% to FRE
Mount Logan spent 2025 remaking itself: redomiciled to the US, moved to Nasdaq under ticker MLCI, converted to US GAAP, closed the 180 Degree Capital business combination, and built a credit-focused p...
- 2025 was transformational: Mount Logan redomiciled to the US, converted from IFRS to US GAAP, listed on Nasdaq (MLCI), and completed the 180 Degree Capital business combination, creating a credit-focused asset management and insurance platform.
- Company-reported total assets under management are about $2.1 billion, with insurance or insurance-related AUM around $1.1 billion after repositioning Ability.
- Management announced a definitive agreement for SOFIX to acquire the Yieldstreet Alternative Income Fund portfolio, a deal expected to add over $100 million to SOFIX net assets and nearly double that vehicle.
- +15 more takeaways
Kolibri Global Energy Q4 2025 Earnings Call - 15% production growth, cautious but flexible drilling plan as prices climb
Kolibri delivered a year of operational momentum despite a brutal price backdrop. Production rose 15% to 4,013 BOE per day in 2025, with December topping 5,600 BOE/d, driving a three-year compound ann...
- Production up 15% in 2025 to 4,013 BOE/day, December production exceeded 5,600 BOE/day; three-year production CAGR is ~35%.
- Operating expense per BOE improved to $7.33 in 2025 from $7.44 in 2024, signalling continued operational efficiency.
- Net revenue fell to $56.9 million, down 3% year over year, driven by a steep decline in realized prices during 2025.
- +10 more takeaways
Gold Royalty Corp. Q4 2025 Earnings Call - Record revenue, positive free cash flow and Pedra Branca acquisition fuels growth
Gold Royalty closed 2025 with record quarterly and full-year revenue and adjusted EBITDA, a third consecutive quarter of positive free cash flow, and a materially strengthened balance sheet after a $1...
- Q4 2025 results set new records: adjusted EBITDA of $3.2 million and total revenue, land agreement proceeds and interest of $5.2 million (1,255 GEO in the quarter).
- Full-year 2025: $17.8 million in total revenue and $9.8 million of adjusted EBITDA, up 38% and 104% year over year respectively.
- Third consecutive quarter of positive free cash flow, which management says establishes a self-funding foundation for growth.
- +12 more takeaways
Aveanna Healthcare Holdings Fourth Quarter 2025 Earnings Call - Preferred payer push and rate gains are normalizing volumes and margins
Aveanna closed 2025 with clear evidence that its preferred payer strategy and targeted rate wins are converting into revenue, margin and cash flow recovery, even as the company continues to wrestle wi...
- Q4 revenue was $662.5 million, up 27.4% year over year; full year 2025 revenue was $2.433 billion, up 20.2%.
- Q4 Adjusted EBITDA was $85 million, up 54% year over year; full year 2025 Adjusted EBITDA was $320.8 million, up 74.8%.
- Results benefitted from a 53rd week in the fiscal year, which boosted revenue and earnings versus a typical year.
- +16 more takeaways
"Cardinal Infrastructure Group" Full Year 2025 Earnings Call - Record $682M Backlog and M&A plus vertical integration power a 2026 guide above 20% adjusted EBITDA
Cardinal closed 2025 with a strong growth burst, a December IPO, and a company-record $682 million backlog, then quickly bolted on a large Georgia acquisition to push 2026 guidance toward $665 million...
- Revenue grew 45% in 2025 to $456 million, with approximately 33% organic growth year-over-year.
- Company completed its IPO in December 2025, and raised nearly $140 million through financing activities during the year.
- Year-end backlog hit a company record $682 million, roughly 1.5x 2025 revenue, providing strong coverage for 2026 guidance.
- +14 more takeaways
Lifezone Metals 2025 Full Year Earnings Call - Kabanga on the cusp of FID as strategic funding and project finance paths converge
Lifezone presented a tightly scripted march toward a final investment decision for the Kabanga Nickel Project. The company published a bankable feasibility study in July 2025 showing a $1.58 billion a...
- Feasibility study published July 2025 yields after-tax NPV of $1.58 billion and a 23.3% IRR, placing Kabanga in the lower quartile cost curve versus peers.
- Lifezone has completed resettlement actions and S-K 1300 initial assessment, advancing development readiness and social license in Tanzania.
- A $60 million senior secured bridge facility from Taurus Mining Finance is ring-fenced for Kabanga; $20 million drawn in 2025 and a further $5 million drawn as a subsequent event.
- +12 more takeaways
Darden Restaurants Fiscal 2026 Q3 Earnings Call - Same-Restaurant Sales Outperformance Widens, Guidance Raised
Darden reported a strong Fiscal 2026 third quarter, with total sales of $3.3 billion (up 5.9%) and same-restaurant sales up 4.2%, widening its outperformance versus the casual dining benchmark. Manage...
- Q3 results: Total sales $3.3 billion, up 5.9% year-over-year; same-restaurant sales +4.2% and outperformed the Black Box Intelligence casual dining benchmark by ~540 basis points.
- Company raised full-year cadence: now expects FY26 total sales growth of ~9.5%, same-restaurant sales ~4.5%, about 70 new restaurant openings, commodities inflation ~4%, and adjusted diluted EPS $10.57-$10.67 (includes ~ $0.25 from a 53rd week).
- Q4 implied guide: total sales growth 13.0%-14.5% (includes extra week), same-restaurant sales 3.5%-5.0%, and adjusted diluted EPS $3.59-$3.69.
- +14 more takeaways
Destination XL Group Q4 2025 Earnings Call - FiTMAP rollout and FullBeauty merger provide strategic runway as comps lag
Destination XL closed FY25 with comps that kept the chain in retreat, reporting Q4 comparable sales down 7.3% and full-year comps down 8.4%, hit hardest by a January Arctic storm that knocked a third ...
- Comparable sales declined 7.3% in Q4 2025, with stores down 8.6% and direct down 4.3%; full-year comparable sales fell 8.4%.
- January was heavily impacted by severe Arctic weather, pushing January comps to minus 12.9%; management reports a rebound with February at minus 1.3% and March following a similar trend.
- Management expects comps to improve through H1 2026, target break even before summer, and turn positive later in the year; no formal fiscal 2026 guidance will be issued until after the FullBeauty merger closes.
- +12 more takeaways